Annovis Bio Stock Performance
as on September 18, 2025 at 1:29 am IST
Day's Low
Day's High
$2.32$2.43
1.28%
Downside
3.40%
Upside
52 Week's Low
52 Week's High
$1.11$10.5452.77%
Downside
348.51%
Upside
Annovis Bio share price movements today
- Previous Close
- $2.37
- Open
- $2.40
- Volume
- 188.6K
- Day's Low - High
- $2.32 - $2.43
- 52 Week Low - High
- $1.11 - $10.54
Annovis Bio Historical Returns
- 1 Month Return
- -13.5 %
- 3 Month Return
- -9.89 %
- 1 Year Return
- -72.88 %
- 3 Year Return
- -88.06 %
- 5 Year Return
- -53.98 %
Annovis Bio Stock Fundamentals & Key Indicators
Check Annovis Bio market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$46.2M
EPS (TTM)
-1.09
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0P/B Ratio
0PEG Ratio
0EBITDA
-
Revenue (TTM)
-
Profit Margin
0.00%
Return On Equity TTM
2805100.00%
Annovis Bio vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Annovis Bio with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $46.2M | -53.98% | NA | 0.00% | |
| BUY | $60.5B | 252.04% | -505.15 | -12.96% | |
| NA | $39.0B | NA | NA | -3.89% | |
| BUY | $100.3B | 44.17% | 27.85 | 31.86% | |
| BUY | $59.6B | 1.78% | 14.1 | 31.37% |
Stock Returns calculator for Annovis Bio Stock including INR - Dollar returns
The Annovis Bio stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Annovis Bio investment value today
Current value as on today
₹31,486
Returns
Returns from Annovis Bio Stock
Dollar Returns*
₹4,598 (+4.6%)
Analyst Recommendation on Annovis Bio Stock
Based on 11 analysts
72.73%
Buy
27.27%
Hold
0.00%
Sell
Based on 11 analysts, 72.73% of analysts recommend a 'BUY' rating for Annovis Bio. Average target price of $13.75
Annovis Bio Share Price Target
Get share price movements and forecasts by analysts on Annovis Bio.
What analysts predicted
82.91%UPSIDE
Target Price
$13.75
Current Price
$2.35
Analyzed by
11 Analysts
Target
$13.75
Annovis Bio target price $13.75, a slight upside of 82.91% compared to current price of $2.35. According to 11 analysts rating.
Annovis Bio Stock's Interest Amongst Investors
Search interest for Annovis Bio Stock has decreased by -18% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Annovis Bio Quarterly Profit & Loss
All numbers in Millions USD
Annovis Bio Annual Profit & Loss
All numbers in Millions USD
Annovis Bio Quarterly Cash Flow
All numbers in Millions USD
Annovis Bio Annual Cash Flow
All numbers in Millions USD
Global Institutional Holdings in Annovis Bio
Insights on Annovis Bio
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
NO EFFECTAgainst Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 116.5% return, outperforming this stock by 204.6%
- NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 68.9% return, outperforming this stock by 140.6%
NEGATIVE IMPACTPrice Dip
In the last 1 month, ANVS stock has moved down by -11.9%
About Annovis Bio
| Organisation | Annovis Bio |
| Headquarters | 101 Lindenwood Drive, Malvern, PA, United States, 19355 |
| Industry | Electronic Equipment/Instruments |
| CEO | Dr. Maria L. Maccecchini Ph.D. |
| E-voting on shares | Click here to vote |
Key Management of Annovis Bio
Name | Title |
|---|---|
Mr. Blake Jensen M.B.A. | Head of Quality |
Ms. Hilda Maibach | Senior Vice President of Statistics |
Dr. Maria L. Maccecchini Ph.D. | Founder, CEO, President, Executive Director & Acting CFO |
Dr. Cheng Fang Ph.D. | Senior Vice President of Research & Development |
Ms. Eve M. Damiano M.S., RAC | Senior Vice President of Regulatory Operations |
Ms. Melissa Gaines | Senior Vice President of Clinical Operations |
FAQs
What is Annovis Bio share price today?
Annovis Bio share price today is $2.35 as on at the close of the market. Annovis Bio share today touched a day high of $2.43 and a low of $2.32.
What is the 52 week high and 52 week low for Annovis Bio share?
Annovis Bio share touched a 52 week high of $10.54 on and a 52 week low of $1.11 on . Annovis Bio stock price today i.e. is closed at $2.35,which is 77.70% down from its 52 week high and 111.71% up from its 52 week low.
What is Annovis Bio's market capitalisation today?
Annovis Bio market capitalisation is $0.00T as on .
How to invest in Annovis Bio Stock (ANVS) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Annovis Bio on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Annovis Bio Shares that will get you 0.6383 shares as per Annovis Bio share price of $2.35 per share as on September 18, 2025 at 1:29 am IST.
What is the minimum amount required to buy Annovis Bio Stock (ANVS) from India?
Indian investors can start investing in Annovis Bio (ANVS) shares with as little as ₹87.816 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹878.16 in Annovis Bio stock (as per the Rupee-Dollar exchange rate as on ).
Based on Annovis Bio share’s latest price of $2.35 as on September 18, 2025 at 1:29 am IST, you will get 4.2553 shares of Annovis Bio. Learn more about
fractional shares .
What are the returns that Annovis Bio has given to Indian investors in the last 5 years?
Annovis Bio stock has given -53.98% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?